|
|
Article: J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc.
- Article from:
- PR Newswire
- Article date:
- April 28, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
RESEARCH TRIANGLE PARK, N.C., April 28 /PRNewswire/ -- Tryton Medical, Inc. announced today that it has appointed J. Greg Davis as President and Chief Executive Officer. Founded in 2003, Tryton Medical is the leading developer of stents that are designed to definitively treat bifurcation lesions.
Mr. Davis joins Tryton Medical after a successful 20-year career with Guidant and Eli Lilly & Company. Mr. Davis is an experienced medical device executive with broad global and functional experience in finance, manufacturing, sales and general management. Most recently he was president of Guidant, Japan with profit and loss responsibility for the company's $225 million ...
Related newspaper, magazine, and journal articles:
|
|
Article: Tryton Medical's Side-Branch Stent(TM) Treats ...
Business Wire;
October 10, 2006 ;
700+ words
... ... Hospital Complications NEWTON, Mass. -- Tryton Medical, Inc., a leading developer of stents ... and delayed) as well as restenosis. Tryton Medical, Inc. initiated a multi-center ... branch," said Richard Davis, CTO, Tryton Medical, Inc. About Tryton Medical, Inc ...
|
|